Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07470606 · ClinicalTrials.gov registry record · Phase 2
Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain
A Phase 2 study, sponsored by The University of Texas Health Science Center at San Antonio.
- Not yet
- Registry status
- Phase 2
- Development phase
- 108
- Enrollment target
NCT07470606: Clinical Trial Phase 2 study, sponsored by The University of Texas Health Science Center at San Antonio.
NCT07470606 is a Phase 2 study that has not yet begun recruiting, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 108 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (19% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07470606, a Phase 2 study, has not yet begun recruiting, sponsored by The University of Texas Health Science Center at San Antonio.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 108 participants
- Enrollment target
Study Summary
The study investigators are testing to see if patients receiving radiation treatment for brain cancer along with raloxifene plus memantidine take longer to develop memory issues. The study will include anyone over the age of 18 who will be treated with radiation for brain cancer.
Primary Outcome
MRIs will be used to capture any changes in hippocampal volume
Interventions
- DRUG Memantine
- DRUG Raloxifene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2026-03 |
| Est. Completion | 2031-03 |
| Phase | Phase 2 |
What is known before NCT07470606 opens enrollment
NCT07470606 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (19% lower).
The record links to 0 conditions, and to 2 interventions - of which Memantine is the first listed.
NCT07470606 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07470606 about?
NCT07470606 is a clinical study titled "Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain". The study investigators are testing to see if patients receiving radiation treatment for brain cancer along with raloxifene plus memantidine take longer to develop memory issues. The study will include anyone over the age of 18 who will be treated with radiation for brain cancer.
What is the current status of trial NCT07470606?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 108 participants. The study started on 2026-03. Estimated completion is 2031-03.
What interventions are being tested in trial NCT07470606?
The interventions under investigation include: Memantine (DRUG), Raloxifene (DRUG).
Who is sponsoring clinical trial NCT07470606?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07470606's enrollment target sits among peer trials
108 640th of 2000 higher than 1,355 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia